The paradoxical effects of interleukin 10 in the immunoregulation of autoimmune diabetes

被引:50
|
作者
Balasa, B [1 ]
Sarvetnick, N [1 ]
机构
[1] Scripps Res Inst, DEPT NEUROPHARMACOL, LA JOLLA, CA 92037 USA
关键词
IDDM; IL-10; NOD; transgenic; T helper;
D O I
10.1006/jaut.1996.0036
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Insulin-dependent diabetes mellitus (IDDM) is a chronic autoimmune disease and spontaneously develops in NOD mice and humans. The role of T helper 1 (Th1) and T helper 2 (Th2) cytokines in the immunopathogenesis of disease is not understood. IL-10 has presented a particularly paradoxical role. Transgenic (Tg) BALB/c mice expressing IL-10 in the pancreas exhibited periinsulitis but not insulitis and diabetes. However, backcrossing of these Tg mice with NOD mice accelerated the onset of diabetes, indicating a pathogenic role for IL-IO in the pathogenesis of autoimmune diabetes since it is able to replace the genetic susceptibility information on the NOD genome. Conversely, administration of IL-10 to adult NOD delayed the onset of and decreased the incidence of diabetes suggesting a potential therapeutic role for IL-10 in autoimmune diabetes. Overall, the findings indicated a paradoxical role for IL-10 in the immunoregulation of autoimmune diabetes. (C) 1996 Academic Press Limited
引用
收藏
页码:283 / 286
页数:4
相关论文
共 50 条
  • [41] Interleukin-10 genes and autoimmune responses in systemic sclerosis
    Hudson, L
    Rocca, K
    Kuwana, M
    Pandey, J
    FASEB JOURNAL, 2005, 19 (04): : A351 - A351
  • [42] Role of Interleukin 10 Transcriptional Regulation in Inflammation and Autoimmune Disease
    Iyer, Shankar Subramanian
    Cheng, Genhong
    CRITICAL REVIEWS IN IMMUNOLOGY, 2012, 32 (01) : 23 - 63
  • [43] Immunoregulation of experimental autoimmune encephalomyelitis: editorial overview
    Miller, SD
    Shevach, EM
    RESEARCH IN IMMUNOLOGY, 1998, 149 (09): : 753 - 759
  • [44] Systemic delivery of interleukin 10 by intramuscular injection of expression plasmid DNA prevents autoimmune diabetes in nonobese diabetic mice
    Nitta, Y
    Tashiro, F
    Tokui, M
    Shimada, A
    Takei, I
    Tabayashi, K
    Miyazaki, J
    HUMAN GENE THERAPY, 1998, 9 (12) : 1701 - 1707
  • [45] T-cell production of an inducible interleukin-10 transgene provides limited protection from autoimmune diabetes
    Pauza, ME
    Neal, H
    Hagenbaugh, A
    Cheroutre, H
    Lo, D
    DIABETES, 1999, 48 (10) : 1948 - 1953
  • [46] Immunoregulation of murine leishmaniasis by interleukin-12
    Heinzel, FP
    Ahmed, F
    Hujer, AM
    Rerko, RM
    RESEARCH IN IMMUNOLOGY, 1995, 146 (7-8): : 575 - 582
  • [47] THE ROLE OF INTERLEUKIN-2 IN IMMUNOREGULATION OF ERYTHROPOIESIS
    BURDACH, ST
    LEVITT, L
    BLOOD CELLS, 1987, 13 (1-2): : 314 - 314
  • [48] Diabetes - Paradoxical effects of tightly controlled blood sugar
    Taubes, Gary
    SCIENCE, 2008, 322 (5900) : 365 - 367
  • [49] Interleukin-6 and Interleukin-15 as Possible Biomarkers of the Risk of Autoimmune Diabetes Development
    Siewko, Katarzyna
    Maciulewski, Rafal
    Zielinska-Maciulewska, Anna
    Poplawska-Kita, Anna
    Szumowski, Piotr
    Wawrusiewicz-Kurylonek, Natalia
    Lipinska, Danuta
    Milewski, Robert
    Gorska, Maria
    Kretowski, Adam
    Szelachowska, Malgorzata
    BIOMED RESEARCH INTERNATIONAL, 2019, 2019
  • [50] Interleukin 23-interleukin 17 immune pathway is involved in the induction of autoimmune diabetes.
    Lukic, Miodrag L.
    Mensah-Brown, Eric P. K.
    Al-Shamisi, Mariam B.
    Shahin, Allen
    Al Hakim, Ahmed
    JOURNAL OF IMMUNOLOGY, 2006, 176 : S159 - S160